- •DEDICATION
- •PREFACE
- •CONTRIBUTORS
- •INSTRUCTIONS TO USERS
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •generic name: Zidovudine.
- •Primary use
- •Ocular side effects
- •Systemic administration (oral or intravenous)
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Amebicides
- •generic names: 1. Broxyquinoline; 2. diiodohydroxyquinoline (iodoquinol).
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Emetine hydrochloride.
- •Primary use
- •Ocular side effects
- •Inadvertent ocular exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Anthelmintics
- •generic name: Diethylcarbamazine citrate.
- •Primary use
- •Ocular side effects
- •Local ophthalmic use or exposure – topical application
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Mepacrine hydrochloride.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Inadvertent direct ocular exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Piperazine.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Thiabendazole.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Class: AntibiOtics
- •generic name: Amikacin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Bacitracin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •Inadvertent orbital injection (ointment)
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Chloramphenicol.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •Local ophthalmic use or exposure – intracameral injection
- •systemic side effects
- •Local ophthalmic use or exposure
- •clinical significance
- •Recommendations for topical ocular chloramphenicol
- •REFERENCES AND FURTHER READING
- •generic name: Ciprofloxacin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application
- •Systemic reactions from topical ocular medication
- •Conditional/Unclassified
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic names: 1. Demeclocycline; 2. doxycycline; 3. minocycline; 4. oxytetracycline; 5. tetracycline.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: filgrastim.
- •Primary use
- •Ocular side effect
- •Systemic administration – intravenous
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application
- •Systemic reactions from topical ocular medication
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Gentamicin sulfate.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •Local ophthalmic use or exposure – intravitreal or intraocular injection
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Kanamycin sulfate.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – subconjunctival injection
- •REFERENCES AND FURTHER READING
- •generic name: Linezolid.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •generic name: Nalidixic acid.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Neomycin.
- •Primary use
- •Ocular side effects
- •Systemic administration (neomycin powder to mucus membranes)
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Nitrofurantoin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Polymyxin B sulfate.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic names: 1. Sulfacetamide; 2. sulfafurazole (sulfisoxazole); 3. sulfamethizole; 4. sulfamethoxazole; 5. sulfanilamide; 6. sulfasalazine; 7. sulfathiazole.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application
- •Conditional/Unclassified
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Telithromycin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Probable
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Tobramycin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application
- •Inadvertent ocular exposure – intraocular injection
- •Inadvertent ocular exposure – subconjunctival injection
- •Inadvertent ocular exposure – ointment in anterior chamber
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Antifungal Agents
- •generic name: Amphotericin B.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – topical application or subconjunctival injection
- •Local ophthalmic use or exposure – intracameral injection
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Griseofulvin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES
- •Class: Antileprosy Agents
- •generic name: Clofazimine.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Dapsone.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic names: 1. Chloroquine; 2. hydroxychloroquine.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations for hydroxychloroquine
- •Recommendations for chloroquine
- •caution
- •REFERENCES AND FURTHER READING
- •generic name: Mefloquine hydrochloride.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Quinine.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Antiprotozoal Agents
- •generic name: Metronidazole.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Suramin sodium.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Tryparsamide.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Antitubercular Agents
- •generic name: Cycloserine.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Ethambutol.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •generic name: Ethionamide.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Isoniazid.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Rifabutin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Rifampicin.
- •Primary use
- •Systemic
- •Ophthalmic
- •Ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure (ointment)
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Thioacetazone (Amithiozone).
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Analeptics
- •generic name: Gabapentin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Lamotrigine.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Vigabatrin.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Benzfetamine hydrochloride; 2. amfepramone hydrochloride (diethylpropion); 3. phendimetrazine tartrate; 4. phentermine.
- •REFERENCES AND FURTHER READING
- •class: antianxiety agents
- •Generic names: 1. Alprazolam; 2. chlordiazepoxide; 3. clonazepam; 4. clorazepate dipotassium; 5. diazepam; 6. flurazepam; 7. lorazepam; 8. midazolam; 9. oxazepam; 10. temazepam; 11. triazolam.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Carisoprodol; 2. meprobamate.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: anticonvulsants
- •Generic names: 1. Ethosuximide; 2. methsuximide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Ethotoin.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Phenytoin.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Ocular teratogenic effects (fetal hydantoin syndrome)
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Sodium valproate; 2. valproate semisodium; 3. valproic acid.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Topiramate.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Ocular teratogenic effects
- •clinical significance
- •Recommendations (Fraunfelder, Fraunfelder and Keates)
- •REFERENCES AND FURTHER READING
- •Generic name: Zonisamide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: antidepressants
- •Generic names: 1. Amitriptyline; 2. desipramine hydrochloride; 3. nortriptyline hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Amoxapine; 2. clomipramine hydrochloride; 3. doxepin hydrochloride; 4. trimipramine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Carbamazepine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Citalopram hydrobromide; 2. fluoxetine hydrochloride; 3. fluvoxamine maleate; 4. paroxetine hydrochloride; 5. sertaline.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Isocarboxazid; 2. phenelzine; 3. tranylcypromine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: Maprotiline.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Methylphenidate hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration – oral
- •Systemic administration – intravenous
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Trazodone.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: antipsycHotic agents
- •Generic names: 1. Chlorpromazine; 2. fluphenazine; 3. perphenazine; 4. prochlorperazine; 5. promethazine; 6. thiethylperazine; 7. thioridazine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Droperidol; 2. haloperidol.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Lithium carbonate.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Loxapine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Pimozide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Quetiapine fumarate.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic names: Tiotixene.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: Psychedelic agents
- •Generic names: 1. Dronabinol (tetrahydrocannabinol, THC); 2. hashish; 3. marihuana (marijuana).
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Lysergic acid diethylamide (LSD), lysergide; 2. mescaline; 3. psilocybin.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Topical ocular application – liquid LSD
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Phencyclidine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: Sedatives and Hypnotics
- •Generic names: 1. Amobarbital; 2. butalbital; 3. methohexital; 4. methylphenobarbital (mephobarbital); 5. pentobarbital; 6. phenobarbital; 7. primidone; 8. secbutabarbital; 9. secobarbital.
- •Primary use
- •ocular side effects
- •Systemic administration (Primarily excessive dosage or chronic use)
- •Ocular teratogenic effects (primidone)
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Chloral hydrate.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: agents used to treat gout
- •Generic name: Allopurinol.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name: Colchicine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Inadvertent ocular exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: antirheumatic agents
- •Generic name: 1. Adalimumab; 2. etanercept; 3. infliximab.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Auranofin; 2. aurothioglucose; 3. sodium aurothiomalate (gold sodium thiomalate).
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Celecoxib; 2. etolodac; 3. nimesulide; 4. rofecoxib; 5. valdecoxib.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Fenoprofen calcium.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Flurbiprofen.
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Ibuprofen.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Indometacin (indomethacin).
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure - topical ocular
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Ketoprofen.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: naproxen.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Piroxicam.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: Mild analgesics
- •Generic names: Aspirin (acetylsalicylic acid).
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Codeine; 2. dextropropoxyphene.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: Paracetamol (acetaminophen).
- •Primary use
- •ocular side effects
- •Systemic administration
- •Possible
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: narcotic antagonists
- •Generic names: 1. naloxone hydrochloride; 2. naltrexone.
- •Primary use
- •ocular side effects
- •Local ophthalmic use or exposure (naloxone)
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: Strong analgesics
- •Generic name: Diacetylmorphine (diamorphine, heroin).
- •Primary use
- •ocular side effects
- •Systemic administration
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Hydromorphone hydrochloride (dihydromorphinone); 2. oxymorphone hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Methadone hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Morphine; 2. opium.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure – morphine
- •Epidural or intravenous exposure
- •Ocular teratogenic effects
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Pethidine hydrochloride (meperidine).
- •Primary use
- •ocular side effects
- •Systemic administration
- •Inadvertent ocular exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Pentazocine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: adjuncts to anesthesia
- •Generic name: Hyaluronidase.
- •Primary use
- •ocular side effects
- •Subconjunctival or retrobulbar injection
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: 1. Hyoscine (scopolamine); 2. hyoscine methobromide (methscopolamine).
- •Primary use
- •Systemic
- •Topical
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Local ophthalmic use or exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Suxamethonium chloride (succinylcholine).
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •Recommendations for use in open globe (after chidiac 2004)
- •REFERENCES AND FURTHER READING
- •class: General anesthesia
- •Generic name: Ether (anesthetic ether).
- •Primary use
- •ocular side effects
- •Systemic administration
- •Inadvertent ocular exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Ketamine hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Methoxyflurane.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: nitrous oxide.
- •Primary use
- •ocular side effects.
- •Systemic administration
- •Intravitreal injection of gas during vitrectomy
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic name: Propofol.
- •Primary use
- •ocular side effects
- •Intravenous administration
- •Accidental ocular exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: local anesthetics
- •Generic names: 1. Bupivacaine hydrochloride; 2. chloroprocaine hydrochloride; 3. lidocaine; 4. mepivacaine hydrochloride; 5. prilocaine; 6. procaine hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration – spiral, caudal, epidural, extradural injections
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: tHerapeutic Gases
- •Generic name: Carbon dioxide.
- •Primary use
- •ocular side effects
- •Systemic administration – extreme concentrations
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Generic names: Oxygen, oxygen-ozone.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •class: agents used to treat acid Peptic disorders
- •Generic names: 1. Cimetidine; 2. famotidine; 3. nizatidine; 4. ranitidine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •clinical significance
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •generic names: 1. Ergometrine maleate (ergonovine); 2. ergotamine tartrate; 3. methylergometrine maleate (methylergonovine).
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: antianginal agents
- •generic name: 1. Amyl nitrite; 2. butyl nitrite.
- •Primary use
- •ocular side effects
- •Inhalation administration
- •Topical ocular application – inadvertent contact with liquid
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic names: 1. Diltiazem hydrochloride; 2. nifedipine; 3. verapamil hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •generic names: 1. flecainide acetate; 2. procainamide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: nitroglycerin.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: antiarrythmic agents
- •generic name: Amiodarone.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •recommendations
- •REFERENCES AND FURTHER READING
- •generic name: Disopyramide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Methacholine chloride.
- •Primary use
- •Ophthalmic
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: 1. Oxprenolol hydrochloride; 2. propranolol hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Quinidine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: antihypertensive agents
- •generic names: 1. Acebutolol; 2. atenolol; 3. carvedilol; 4. labetolol hydrochloride; 5. metoprolol; 6. nadolol; 7. pindolol.
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: 1. Alfuzosin hydrochloride; 2. doxazosin; 3. tamsulosin; 4. terazosin.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic names: 1. Captopril; 2. enalapril.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Clonidine.
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Diazoxide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Guanethidine monosulfate.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Hydralazine hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Minoxidil.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Topical application
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Prazosin hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic names: 1. Rescinnamine; 2. reserpine.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: BronChodilators
- •generic name: Ipratropium.
- •Primary use
- •ocular side effects
- •Systemic administration – solution, aerosols or nasal sprays
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Salbutamol (albuterol).
- •Primary use
- •ocular side effects
- •Systemic administration – nebulizer
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: diuretics
- •generic names: 1. Bendroflumethiazide; 2. chlorothiazide; 3. chlortalidone; 4. hydrochlorothiazide; 5. hydroflumethiazide; 6. indapamide; 7. methyclothiazide; 8. metolazone; 9. polythiazide; 10. trichlormethiazide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: furosemide.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Osmotics
- •generic name: Glycerol (glycerin).
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Mannitol.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Peripheral Vasodilators
- •generic name: Phenoxybenzamine hydrochloride.
- •Primary use
- •ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Class: Vasopressors
- •generic name: Ephedrine.
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: 1. Epinephrine; 2. norepinephrine (levaterenol).
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration – injection
- •Local ophthalmic use or exposure
- •Systemic side effects
- •Local ophthalmic use or exposure – epinephrine
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •generic name: Phenylephrine.
- •Primary use
- •Systemic
- •Ophthalmic
- •ocular side effects
- •Systemic administration – nasal application
- •Local ophthalmic use or exposure
- •Systemic side effects
- •Local ophthalmic use or exposure
- •Conditional/Unclassified
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Intraocular injection
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •Systemic
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration (toxic levels)
- •Inadvertent ocular exposure
- •REFERENCES AND FURTHER READING
- •Systemic
- •Ophthalmic
- •Intrathecal and intraventricular injections
- •Intracameral injection
- •Local ophthalmic use or exposure
- •REFERENCES AND FURTHER READING
- •Systemic
- •Ophthalmic
- •Systemic administration – intravenous injections
- •Intracrameral injections
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •Local ophthalmic use or exposure – subconjunctival injection
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration – intravenous
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •Ocular teratogenic effects
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration – oral
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •Class: Antihistamines
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •Ocular side effects
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •Local ophthalmic use or exposure – mitomycin
- •REFERENCES AND FURTHER READING
- •Systemic administration – intravenous
- •Ocular teratogenic effects
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration – intraveneous
- •Systemic administration – intracarotid injection
- •REFERENCES AND FURTHER READING
- •Systemic administration – intravenous
- •REFERENCES AND FURTHER READING
- •Systemic administration – intravenous
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic
- •Ophthalmic
- •Systemic administration
- •Local ophthalmic use or exposure
- •REFERENCES AND FURTHER READING
- •Systemic administration – intravenous
- •REFERENCES AND FURTHER READING
- •Systemic administration – intracarotid injection
- •REFERENCES AND FURTHER READING
- •Systemic
- •Ophthalmic
- •Systemic administration
- •Injection into the eyelid (fluorouracil)
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration (intramuscular, subcutaneous or intravenous injections)
- •REFERENCES AND FURTHER READING
- •Ocular side effects
- •Systemic administration (interleukin 2)
- •Subcutaneous administration (interleukin 3 and 6)
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •Ocular teratogenic effects
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic administration
- •REFERENCES AND FURTHER READING
- •Systemic
- •Ophthalmic
- •Systemic administration (intravenous, intramuscular)
- •Local ophthalmic use or exposure
- •clinical significance
- •REFERENCES AND FURTHER READING
- •Systemic administration (vincristine unless stated)
- •Inadvertent ocular exposure – vinblastine
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFERENCES AND FURTHER READING
- •REFEREnCEs AnD FuRTHER READInG
- •Chemical-induced ocular side effects
- •Class: acids
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Hydrofluoric acid
- •Hydrochloric acid
- •Sulfuric acid
- •Ocular side effects
- •Direct ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: Aerosols
- •Generic names:
- •synonyms:
- •Primary use
- •Ocular side effects
- •Direct ocular exposure
- •Defective or improper delivery – powder form of CS and CN
- •systemic side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •Proprietary name:
- •Primary use
- •Ocular side effects
- •Systemic administration – acute intoxication
- •Systemic administration – chronic intoxication
- •Ocular teratogenic effects (fetal alcohol syndrome)
- •Local ophthalmic use or exposure – retrobulbar injection
- •Inadvertent ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Primary use
- •Ocular side effects
- •Direct ocular exposure
- •Systemic exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Direct ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Systemic exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Direct ocular exposure
- •Systemic exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: Alkali
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical Ocular Exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Direct ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: Bleaches
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: Detergents
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: Glues
- •Generic name:
- •synonyms:
- •Proprietary names:
- •Primary use
- •Ocular side effects
- •Topical Ocular Exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: Herbicides and insecticides
- •Generic name:
- •synonyms:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic names:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Systemic exposure – acute effects
- •Systemic exposure – chronic effects
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: Hydrocarbons
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Systemic exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Class: MisCellaneOus
- •Generic name:
- •synonyms:
- •Proprietary names/products containing:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Generic name:
- •synonyms:
- •Proprietary names:
- •Primary use
- •Ocular side effects
- •Topical ocular exposure
- •Clinical significance
- •Recommendations
- •REFERENCES AND FURTHER READING
- •Herbal medicine and dietary supplement induced ocular side effects
- •Herbal or supplement name: Canthaxanthine.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Local ophthalmic use or exposure
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Herbal or supplement name: Datura.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Herbal or supplement name: Ginkgo biloba.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Herbal or supplement name: Licorice.
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
- •Herbal or supplement name: Retinol (Vitamin A).
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FuRTHER READING
- •Primary use
- •Ocular side effects
- •Systemic administration
- •Clinical significance
- •REFERENCES AND FURTHER READING
Weir REP, Whitehead DEJ, Zaidi FH, et al. Pupil blown by a puffer. Lancet 363: 2004, 1853.
Woelfle J, Zielen S, Lentze MJ. Unilateral fixed dilated pupil in an infant after inhalation of nebulized ipratropium bromide. J Pediatr 136: 423–424, 2000.
Generic name: Salbutamol (albuterol).
Proprietary names: Accuneb, Proventil, Proair, Ventolin, Vospire.
Primary use
This sympathomimetic amine is primarily used as a broncho dilator in the symptomatic relief of bronchospasm.
Ocular side effects
Systemic administration – nebulizer
Certain
1. Decreased vision
2. Eyelids or conjunctiva
a.Erythema
b.Blepharoconjunctivitis
c.Edema
d.Angioneurotic edema
e.Urticaria
3. Mydriasis – may precipitate angle-closure glaucoma 4. Ocular pain
Probable
1. Visual hallucinations
Clinical significance
Oral salbutamol has no reported adverse ocular effects. This beta- agonist only has significant ocular side effects if delivered via a nebulizer with the drug coming into direct contact with the eye. Methods to prevent ocular contact will completely prevent all ocular effects. Salbutamol can cause mydriasis and may increase intraocular pressure in predisposed narrow angles. This drug is often given also in nebulized form with ipratropium and will induce angle-closure glaucoma by its parasympathetic inhibitory effect. In a study by Kalra and Bone (1988), both salbutamol and ipratropium were administered simultaneously via nebulizers without eye protection and all patients with narrow angles had an increase in intraocular pressure. Transient angle closure occurred in 50% of them. This effect was completely prevented when protective eye goggles were worn. Contact of this drug with the eye and eyelids may occasionally cause transitory irritation and or ocular pain. Visual hallucinations have only been reported in children.
References And Further Reading
Basoglu OK, Emre S, Bacakoglu F, et al. Glaucoma associated with metereddose bronchodilator therapy. Respir Med 95: 844–845, 2001.
Goldstein JB, Biousse V, Newman NJ. Unilateral pharmacologic mydriasis in a patient with respiratory compromise. Arch Ophthalmol 15: 806, 1997.
Kalra L, Bone MF. The effect of nebulized bronchodilator therapy on intra ocular pressures in patients with glaucoma. Chest 93: 739–741, 1988.
Khanna PB, Davies R. Hallucinations associated with the administration of salbutamol via a nebulizer. BMJ 292: 1430, 1986.
Packe GE, Cayton RM, Mashhoudi N. Nebulised ipratopium bromide and salbutamol causing closed-angle glaucoma. Lancet 2: 691, 1984.
Rho DS. Acute angle-closure glaucoma after albuterol nebulizer treatment. Am J Ophthalmol 130: 123–124, 2000.
Shurman A, Passero MA. Unusual vascular reactions to albuterol. Arch Intern Med 144: 1771, 1984.
Class: Diuretics
Generic names: 1. Bendroflumethiazide; 2. chlorothiazide; 3. chlortalidone; 4. hydrochlorothiazide; 5. hydroflumethiazide; 6. indapamide; 7. methyclothiazide; 8. metolazone; 9. polythiazide; 10. trichlormethiazide.
Proprietary names: 1. Naturetin-5; 2. Diuril;
3. Thalitone; 4. Esidrix, Microzide, Oretic; 5. Saluron; 6. Lozol; 7. Enduron; 8. Zaroxolyn; 9. Renese; 10. Metahydrin, Naqua, Trichlorex, Trichlormas.
Primary use
These thiazides and related diuretics are effective in the maintenance therapy of edema associated with chronic congestive heart failure, essential hypertension, renal dysfunction, cirrhosis, pregnancy, premenstrual tension and hormonal imbalance.
Ocular side effects
Systemic administration
Certain
1. Decreased vision
2. Myopia (Fig. 7.6d)
3. Problems with color vision
a.Objects have yellow tinge (chlorothiazide)
b.Large yellow spots on white background 4. Eyelids or conjunctiva
a.Allergic reactions
b.Conjunctivitis – non-specific
c.Photosensitivity
d.Urticaria
e.Purpura
5. Visual hallucinations
6. Choroidal effusion
7. Increased anterior-posterior lens diameter
8. Shallow anterior chambers
9. Acute glaucoma
Probable
1. Retinal edema
2. Decreased lacrimation
3. Decreased intraocular pressure – minimal
4. Paralysis of accommodation
Possible
1. Eyelids or conjunctiva
a.Lupoid syndrome
b.Erythema multiforme
c.Stevens-Johnson syndrome
d.Lyell’s syndrome
e.Toxic epidermal necrolysis
2. Subconjunctival or retinal hemorrhages secondary to druginduced anemia
Clinical significance
Ocular side effects due to these diuretics occur only occasionally and are usually transitory. It appears that most of these agents can cause transitory myopia. There are many different possible mechanisms involved in causing myopia. One is a change directly related to the crystalline lens and ciliary body, i.e. spasm of accommodation, altered sodium-chloride metabolism, ciliary body edema, inhibition of fluid by the lens or change in lenticular index
agents renal and vascular Cardiac, • 6Stionec
161
effects side ocular induced-Drug • 7 Part
Fig. 7.6d Fluorescein angiogram showing islands of delayed filling. Photo courtesy of Blain P, et al: Acute transient myopia induced by indapamide . Am J Ophthalmol 129: 538-540, 2000.
of refraction. The second mechanism is related to changes in the media or sclera, i.e. changes in the refractive index of the media or stretching of the sclera (Jampolsky and Flom 1953). Blain et al (2000), using angiography, showed diffuse choroidal thickening during indapamide induced myopia. Some of the mechanisms proposed for inducing myopia are probably the cause of inducing angle-closure glaucoma. There are well-documented cases of unilateral or bilateral ciliary body edema or effusions, which produce anterior rotation of the ciliary body at the scleral spur, allowing laxity of the lens zonule and forward displacement of the irislens diaphragm. This increases the anterioposterior diameter of the lens, allowing for a shallowing of the anterior chamber with a resultant narrow angle. The cause of the ciliary body edema is unknown; however, Geanon and Perkins (1995) described a case they felt was due to a hypersensitivity reaction. Krieg and Schipper (1996) showed that prostaglandins and eicosanoids are involved. The management of this type of glaucoma is the same as with topiramate. Sponsel and Rapoza (1992) reported a posterior subcapsular cataract after indapamide therapy, but made no statement as to causation. Miller and Moses (1978) described a case of transient oculomotor nerve palsy associated with thiazide-induced glucose intolerance. Thiazide diuretics can also cause hypercalcemia, which may result in band keratopathy.
When thiazide diuretics are used in combination with carbonic anhydrase inhibitors, one should be alert for signs of hypokalemia. These diuretics are photosensitizers and Hartzer et al (1993) showed that in tissue culture hydrochlorothiazide will interact with UV-A radiation to produce toxic synergistic effects
on human RPE cells. de la Mamierre et al (2003), in a case control study, concluded that drug-induced phototoxicity (thiazide diuretics in long-term treatment) may be involved in causing more severe neovascularization in age-related macular degeneration.
References And Further Reading
Ashraf N, Locksley R, Arieff AI. Thiazide-induced hyponatremia associated with death or neurologic damage in outpatients. Am J Med 70: 1163, 1981.
Beasley FJ. Transient myopia during trichlormethiazide therapy. Ann Ophthalmol 12: 705, 1980.
Bergmann MT, Newman BL, Johnson NC Jr. The effect of a diuretic (hydrochlorothiazide) on tear production in humans. Am J Ophthalmol 99: 473, 1985.
Birch J, et al. Acquired color vision defects. In: Congenital and Acquired Color Vision Defects, Pokorny J et al. (eds), Grune & Stratton, New York, p 243–350, 1979.
Blain P, Paques M, Massin P, et al. Acute transient myopia induced by indapamide. Am J Ophthalmol 129: 538–540, 2000.
de la Marnierre E, Guigon B, Quaranta M, et al. Phototoxic drugs and agerelated maculopathy. J Fr Ophtalmol 26: 596–601, 2003.
Geanon JD, Perkins TW. Bilateral acute angle-closure glaucoma associated with drug sensitivity to hydrochlorothiazide. Arch Ophthalmol 113: 1231–1232, 1995.
Grinbaum A, Ashkenazi I, Avni I. Drug induced myopia associated with treatment for gynecological problems. Eur J Ophthalmol 5(2): 136–138, 1995.
Hartzer M, et al. Hydrochlorothiazide: increased human retinal epithelial cell toxicity following low-level UV-A irradiation. ARVO Invest Ophthalmol Vis Sci Annual Meeting Abstract (Issue), 3633–3640, May 1993.
Jampolsky A, Flom B. Transient myopia associated with anterior displacement of the crystalline lens. Am J Ophthalmol 36: 81–89, 1953.
162
